Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$241K Buy
+203,300
New +$16.1M 0.02% 372
2025
Q1
Sell
-18,300
Closed -$14.9K 755
2024
Q4
$14.9K Buy
+18,300
New +$1.35M ﹤0.01% 594
2024
Q1
Sell
-12,900
Closed -$9.88K 811
2023
Q4
$9.88K Buy
+12,900
New +$1.32M ﹤0.01% 698
2023
Q3
Sell
-16,100
Closed -$8.62K 1097
2023
Q2
$8.62K Buy
+16,100
New +$1.95M ﹤0.01% 844
2023
Q1
Sell
-11,600
Closed -$10K 1313
2022
Q4
$10K Sell
11,600
-400
-3% -$43.9K ﹤0.01% 1105
2022
Q3
$136K Sell
12,000
-800
-6% -$67.8K 0.01% 716
2022
Q2
$197K Buy
+12,800
New +$1.17M 0.01% 725
2021
Q4
Sell
-47,600
Closed -$87K 2599
2021
Q3
$87K Sell
47,600
-1,200
-2% -$151K ﹤0.01% 1296
2021
Q2
$106K Buy
+48,800
New +$4.69M ﹤0.01% 1202
2021
Q1
Sell
-344,800
Closed -$222K 2031
2020
Q4
$222K Buy
344,800
+15,600
+5% +$1.39M 0.01% 921
2020
Q3
$349K Buy
329,200
+4,400
+1% +$460K 0.02% 491
2020
Q2
$740K Buy
324,800
+12,800
+4% +$1.14M 0.04% 340
2020
Q1
$2.73M Sell
312,000
-204,400
-40% -$12.7M 0.18% 95
2019
Q4
$635K Buy
+516,400
New +$24.5M 0.03% 270

Other funds holding DXCM

HAP Trading's DXCM Position: Q3 2025 in Review

HAP Trading sold out of DexCom (DXCM) in Q3 2025, closing a stake of 18,836 shares — an estimated $1.49M sold.

HAP Trading first reported a position in DXCM in Q4 2019 and held it in 6 quarters. The position peaked at $7.2M in Q4 2019. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • HAP Trading reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • HAP Trading sold 18,836 DexCom shares in Q3 2025, an estimated $1.49M.
  • HAP Trading first reported a position in DexCom in Q4 2019 and held it in 6 quarters.
  • HAP Trading's DexCom position peaked at $7.2M in Q4 2019.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.